纤维蛋白溶解剂活性监测。一项治疗挑战。
Monitoring activity of fibrinolytic agents. A therapeutic challenge.
作者信息
Shafer K E, Santoro S A, Sobel B E, Jaffe A S
出版信息
Am J Med. 1984 May;76(5):879-86. doi: 10.1016/0002-9343(84)91003-9.
PMID:6232847
Abstract
The recognition that thrombolytic therapy may be beneficial for coronary thrombolysis has led to an increased use of plasminogen activators in critically ill patients, sometimes with inadequate monitoring. This review delineates the components of the fibrinolytic system, describes mechanisms of fibrinolysis, and presents practical guidelines for monitoring the use of activators of the system.
摘要
认识到溶栓治疗可能对冠状动脉溶栓有益，这导致纤溶酶原激活剂在重症患者中的使用增加，有时监测不足。本综述阐述了纤维蛋白溶解系统的组成部分，描述了纤维蛋白溶解机制，并提出了监测该系统激活剂使用的实用指南。
相似文献
1
Monitoring activity of fibrinolytic agents. A therapeutic challenge.纤维蛋白溶解剂活性监测。一项治疗挑战。
Am J Med. 1984 May;76(5):879-86. doi: 10.1016/0002-9343(84)91003-9.
2
[Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
Rocz Akad Med Im Juliana Marchlewskiego Bialymst. 1979;24:91-104.
3
Nonradical excited oxygen species induce selective thrombolysis in vivo.非自由基激发态氧物种在体内诱导选择性溶栓。
Thromb Res. 1991 May 1;62(3):147-63. doi: 10.1016/0049-3848(91)90189-4.
4
Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).冠状动脉溶栓：着重于组织型纤溶酶原激活剂（t-PA）的药理学考量
Biochem Pharmacol. 1984 Jun 15;33(12):1831-8. doi: 10.1016/0006-2952(84)90536-7.
5
[Thrombolytics and their use].[溶栓剂及其应用]
Rev Prat. 1999 Oct 1;49(15):1654-8.
6
The search for the ideal thrombolytic agent.对理想溶栓剂的探索。
J Am Coll Cardiol. 1987 Nov;10(5 Suppl B):4B-10B. doi: 10.1016/s0735-1097(87)80421-7.
7
An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.外周和冠状动脉血栓形成的局部与全身溶栓治疗评估。
Prog Hemost Thromb. 1984;7:325-56.
8
The fibrinolytic system in man.人类的纤维蛋白溶解系统。
Crit Rev Oncol Hematol. 1986;4(3):249-301. doi: 10.1016/s1040-8428(86)80014-2.
9
[Acyl enzymes and pro-urokinase: promising new thrombolytic agents].[酰基酶和前尿激酶：有前景的新型溶栓剂]
Haemostasis. 1986;16 Suppl 4:35-9. doi: 10.1159/000215530.
10
Concepts of clot lysis.血栓溶解的概念。
Annu Rev Med. 1986;37:187-204. doi: 10.1146/annurev.me.37.020186.001155.
引用本文的文献
1
Catheter-Directed Thrombolysis for Postpartum Deep Venous Thrombosis.导管定向溶栓治疗产后深静脉血栓形成
Front Cardiovasc Med. 2022 Apr 26;9:814057. doi: 10.3389/fcvm.2022.814057. eCollection 2022.
2
Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fraction.通过凝血酶时间评估链激酶诱导的去纤维蛋白作用：对残余冠状动脉狭窄和左心室射血分数的影响。
Br Heart J. 1992 Aug;68(2):171-5. doi: 10.1136/hrt.68.8.171.
Zotero 插件